Position of the Transparency Council – Lokelma (sodium zirconium cyclosilicate)
At its meeting on 23 December 2024, the Transparency Council adopted position No. 153/2024 on the evaluation of the drug Lokelma (sodium zirconium cyclosilicate) for the indication: treatment of hyperkalemia in adult patients